MHRA Class 4 Medicines Defect Information: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen Healthcare Limited)
Class 4 Medicines Defect Information: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen Healthcare Limited) Drug alert number: EL (24)A/53 Date issued: 07 November 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen [...]
The post MHRA Class 4 Medicines Defect Information: Zoledronic Acid Ennogen 4mg/5ml concentrate for solution for infusion (Ennogen Healthcare Limited) appeared first on Community Pharmacy England.
Recent Comments